Bulimia  >>  lisdexamfetamine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01090713: Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Completed
3
50
US
lisdexamfetamine, Placebo control
Lindner Center of HOPE, Shire, University of Cincinnati
Binge Eating Disorder
10/12
10/12

Download Options